M J Crockett1, L Clark, L D Smillie, T W Robbins. 1. Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, England, UK. mollycrockett@gmail.com
Abstract
RATIONALE: The neurotransmitter serotonin (5-HT) has been implicated in both aversive processing and impulsivity. Reconciling these accounts, recent studies have demonstrated that 5-HT is important for punishment-induced behavioural inhibition. These studies focused on situations where actions lead directly to punishments. However, decision-making often involves making tradeoffs between small 'local' costs and larger 'global' losses. OBJECTIVE: We aimed to distinguish whether 5-HT promotes avoidance of local losses, global losses, or both, in contrast to an overall effect on reflection impulsivity. We further examined the influence of individual differences in sub-clinical depression, anxiety and impulsivity on global and local loss avoidance. METHODS: Healthy volunteers (N = 21) underwent an acute tryptophan depletion procedure in a double-blind, placebo-controlled crossover design. We measured global and local loss avoidance in a decision-making task where subjects could sample information at a small cost to avoid making incorrect decisions, which resulted in large losses. RESULTS: Tryptophan depletion removed the suppressive effects of small local costs on information sampling behaviour. Sub-clinical depressive symptoms produced effects on information sampling similar to (but independent from) those of tryptophan depletion. Dispositional anxiety was related to global loss avoidance. However, trait impulsivity was unrelated to information sampling. CONCLUSIONS: The current findings are consistent with recent theoretical work that characterises 5-HT as pruning a tree of potential decisions, eliminating options expected to lead to aversive outcomes. Our results extend this account by proposing that 5-HT promotes reflexive avoidance of relatively immediate aversive outcomes, potentially at the expense of more globally construed future losses.
RATIONALE: The neurotransmitter serotonin (5-HT) has been implicated in both aversive processing and impulsivity. Reconciling these accounts, recent studies have demonstrated that 5-HT is important for punishment-induced behavioural inhibition. These studies focused on situations where actions lead directly to punishments. However, decision-making often involves making tradeoffs between small 'local' costs and larger 'global' losses. OBJECTIVE: We aimed to distinguish whether 5-HT promotes avoidance of local losses, global losses, or both, in contrast to an overall effect on reflection impulsivity. We further examined the influence of individual differences in sub-clinical depression, anxiety and impulsivity on global and local loss avoidance. METHODS: Healthy volunteers (N = 21) underwent an acute tryptophan depletion procedure in a double-blind, placebo-controlled crossover design. We measured global and local loss avoidance in a decision-making task where subjects could sample information at a small cost to avoid making incorrect decisions, which resulted in large losses. RESULTS: Tryptophan depletion removed the suppressive effects of small local costs on information sampling behaviour. Sub-clinical depressive symptoms produced effects on information sampling similar to (but independent from) those of tryptophan depletion. Dispositional anxiety was related to global loss avoidance. However, trait impulsivity was unrelated to information sampling. CONCLUSIONS: The current findings are consistent with recent theoretical work that characterises 5-HT as pruning a tree of potential decisions, eliminating options expected to lead to aversive outcomes. Our results extend this account by proposing that 5-HT promotes reflexive avoidance of relatively immediate aversive outcomes, potentially at the expense of more globally construed future losses.
Authors: Catharine A Winstanley; Jeffrey W Dalley; David E H Theobald; Trevor W Robbins Journal: Neuropsychopharmacology Date: 2004-07 Impact factor: 7.853
Authors: Shashwath A Meda; Michael C Stevens; Marc N Potenza; Brian Pittman; Ralitza Gueorguieva; Melissa M Andrews; Andre D Thomas; Christine Muska; Jennifer L Hylton; Godfrey D Pearlson Journal: Behav Pharmacol Date: 2009-09 Impact factor: 2.293
Authors: Ilana Frydman; Paulo Mattos; Ricardo de Oliveira-Souza; Murat Yücel; Samuel R Chamberlain; Jorge Moll; Leonardo F Fontenelle Journal: Compr Psychiatry Date: 2019-12-16 Impact factor: 3.735
Authors: James Ja Livermore; Clare L Holmes; Jo Cutler; Maruša Levstek; Gyorgy Moga; James Rc Brittain; Daniel Campbell-Meiklejohn Journal: J Psychopharmacol Date: 2021-02-18 Impact factor: 4.153
Authors: Alejandro Szmulewicz; Cecilia Samamé; Pablo Caravotta; Diego J Martino; Ana Igoa; Diego Hidalgo-Mazzei; Francesc Colom; Sergio A Strejilevich Journal: Int J Bipolar Disord Date: 2016-02-16
Authors: Paul Faulkner; Federico Mancinelli; Patricia L Lockwood; Mar Matarin; Raymond J Dolan; Nick W Wood; Peter Dayan; Jonathan P Roiser Journal: Int J Neuropsychopharmacol Date: 2017-01-01 Impact factor: 5.176
Authors: Raquel Vicario-Feliciano; Rebekah L Wigton; Thomas P White; Sukhi S Shergill; Bruno B Averbeck Journal: J Psychopharmacol Date: 2019-01-15 Impact factor: 4.153
Authors: Naomi A Fineberg; Samuel R Chamberlain; Anna E Goudriaan; Dan J Stein; Louk J M J Vanderschuren; Claire M Gillan; Sameer Shekar; Philip A P M Gorwood; Valerie Voon; Sharon Morein-Zamir; Damiaan Denys; Barbara J Sahakian; F Gerard Moeller; Trevor W Robbins; Marc N Potenza Journal: CNS Spectr Date: 2014-02 Impact factor: 3.790